The association between telomere length and cancer risk in population studies

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhu, Xun ^a   Han, Wei ^b   Xue, Wenjie ^a   Zou, Yuxia ^a   Xie, Cuiwei ^a   Du, Jiangbo ^a   Jin, Guangfu ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Xuzhou Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL TUMOR; GENETICS; HEAD AND NECK TUMOR; HUMAN; META ANALYSIS; RISK ASSESSMENT; RISK FACTOR; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING;

GASTROINTESTINAL NEOPLASMS; HEAD AND NECK NEOPLASMS; HUMANS; RISK ASSESSMENT; RISK FACTORS; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING;

EID: 84959377981     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22243     Document Type: Article

References (81)

1. de Lange, T. et al. Structure and variability of human chromosome ends. Mol Cell Biol 10, 518-27 (1990).
2. Moon, I. K. & Jarstfer, M. B. The human telomere and its relationship to human disease, therapy, and tissue engineering. Front Biosci 12, 4595-4620 (2007).
3. Cairney, C. J. & Keith, W. N. Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity. Biochimie 90, 13-23 (2008).
4. Zhao, Y. et al. Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells. Cell 138, 463-475 (2009).
5. Blackburn, E. H., Greider, C. W. & Szostak, J. W. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat. Med 12, 1133-1138 (2006).
6. Allsopp, R. C. et al. Telomere length predicts replicative capacity of human fibroblasts. Proc. Proc Natl Acad Sci USA 89, 10114-8 (1992).
7. Steffens, J. P., Masi, S., D'Aiuto, F. & Spolidorio, L. C. Telomere length and its relationship with chronic diseases-new perspectives for periodontal research. Arch Oral Biol 58, 111-7 (2013).
8. Daniali, L. et al. Telomeres shorten at equivalent rates in somatic tissues of adults. Nat Commun. 4, 1597 (2013).
9. Wentzensen, I. M., Mirabello, L., Pfeiffer, R. M. & Savage, S. A. The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 20, 1238-50 (2011).
10. Ma, H. et al. Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS One. 6, e20466 (2011).
11. Anic, G. M. et al. Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma. Cancer Epidemiol. 37, 434-9 (2013).
12. Nan, H. et al. Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res. 71, 6758-63 (2011).
13. Han, J. et al. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol. 129, 415-21 (2009).
14. Liang, G., Qureshi, A. A., Guo, Q., De Vivo, I. & Han, J. No association between telomere length in peripheral blood leukocytes and the risk of non-melanoma skin cancer. Cancer Epidemiol Biomarkers Prev. 20, 1043-5 (2011).
15. Burke, L. S. et al. Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. PLoS One. 8, e71121 (2013).
16. Wu, X. et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 95, 1211-8 (2003).
17. Mirabello, L. et al. The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell. 8, 405-13 (2009).
18. Julin, B. et al. Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer. Br J Cancer. 112, 769-76 (2015).
19. Hurwitz, L. M. et al. Telomere length as a risk factor for hereditary prostate cancer. Prostate. 74, 359-64 (2014).
20. Hofmann, J. N. et al. A prospective study of leukocyte telomere length and risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev. 22, 997-1000 (2013).
21. Hofmann, J. N. et al. Risk of renal cell carcinoma in relation to blood telomere length in a population-based case-control study. Br J Cancer. 105, 1772-5 (2011).
22. McGrath, M., Wong, J. Y., Michaud, D., Hunter, D. J. & De Vivo, I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 16, 815-9 (2007).
23. Broberg, K., Björk, J., Paulsson, K., Höglund, M. & Albin, M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis. 26, 1263-71 (2005).
24. Pellatt, A. J., Wolff, R. K., Lundgreen, A., Cawthon, R. & Slattery, M. L. Genetic and lifestyle influence on telomere length and subsequent risk of colon cancer in a case control study. Int J Mol Epidemiol Genet. 3, 184-94 (2012).
25. Cui, Y. et al. Association of leukocyte telomere length with colorectal cancer risk: nested case-control findings from the Shanghai Women's Health Study. Cancer Epidemiol Biomarkers Prev. 21, 1807-13 (2012).
26. Qin, Q. et al. Telomere length in peripheral blood leukocytes is associated with risk of colorectal cancer in Chinese population. PLoS One. 9, e88135 (2014).
27. Hou, L. et al. Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol Biomarkers Prev. 18, 3103-9 (2009).
28. Risques, R. A. et al. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 16, 2649-55 (2007).
29. Yu, Q. et al. Combined effects of leukocyte telomere length, p53 polymorphism and human papillomavirus infection on esophageal squamous cell carcinoma in a Han Chinese population. Cancer Epidemiol. 38, 569-75 (2014).
30. Du, J. et al. Telomere length, genetic variants and gastric cancer risk in a Chinese population. Carcinogenesis. 36, 963-70 (2015).
31. Liu, X. et al. Constitutive telomere length and gastric cancer risk: case-control analysis in Chinese Han population. Cancer Sci. 100, 1300-5 (2009).
32. Xing, J. et al. Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prev Res 2, 459-65 (Phila, 2009).
33. Gramatges, M. M., Telli, M. L., Balise, R. & Ford, J. M. Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls. Cancer Epidemiol Biomarkers Prev. 19, 605-13 (2010).
34. Pellatt, A. J. et al. Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study. Genes Chromosomes Cancer. 52, 595-609 (2013).
35. Shen, J. et al. Telomere length, oxidative damage, antioxidants and breast cancer risk. Int J Cancer. 124, 1637-43 (2009).
36. De Vivo, I. et al. A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 18, 1152-6 (2009).
37. Kim, S. et al. Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis: results from the Sister Study. Cancer Causes Control. 22, 1061-6 (2011).
38. Shen, J. et al. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res. 67, 5538-44 (2007).
39. Zheng, Y. L. et al. Telomere length in blood cells and breast cancer risk: investigations in two case-control studies. Breast Cancer Res Treat. 120, 769-75 (2010).
40. Qu, S. et al. Association of leukocyte telomere length with breast cancer risk: nested case-control findings from the Shanghai Women's Health Study. Am J Epidemiol. 177, 617-24 (2013).
41. Shen, M. et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer. Lung Cancer. 73, 133-7 (2011).
42. Lan, Q. et al. Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China. PLoS One. 8, e59230 (2013).
43. Sanchez-Espiridion, B. et al. Telomere length in peripheral blood leukocytes and lung cancer risk: a large case-control study in Caucasians. Cancer Res. 74, 2476-86 (2014).
44. Seow, W. J. et al. Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts. Cancer Res. 74, 4090-8 (2014).
45. Sun, B. et al. Telomere length variation: A potential new telomere biomarker for lung cancer risk. Lung Cancer. 88, 297-303 (2015).
46. Jang, J. S. et al. Telomere length and the risk of lung cancer. Cancer Sci. 99, 1385-9 (2008).
47. Zhang, Y. et al. Telomere length in peripheral blood lymphocytes contributes to the development of HPV-associated oropharyngeal carcinoma. Cancer Res. 73, 5996-6003 (2013).
48. Bau, D. T. et al. Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma. Cancer. 119, 4277-83 (2013).
49. Lan, Q. et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res. 15, 429-33 (2009).
50. Hosnijeh, F. S. et al. Prediagnostic telomere length and risk of B-cell lymphoma-Results from the EPIC cohort study. Int J Cancer. 135, 2910-7 (2014).
51. Widmann, T. A., Herrmann, M., Taha, N., König, J. & Pfreundschuh, M. Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis. Exp Hematol. 35, 939-46 (2007).
52. Liu, J. et al. Longer leukocyte telomere length predicts increased risk of hepatitis B virus-related hepatocellular carcinoma: a casecontrol analysis. Cancer. 117, 4247-56 (2011).
53. Lynch, S. M. et al. A prospective analysis of telomere length and pancreatic cancer in the alpha-tocopherol beta-carotene cancer (ATBC) prevention study. Int J Cancer. 133, 2672-80 (2013).
54. Fu, X. et al. Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection. Eur J Cancer. 48, 1014-22 (2012).
55. Campa, D. et al. Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length. Int J Cancer. 136, E351-8 (2015).
56. Terry, K. L. et al. Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk. Cancer Epidemiol Biomarkers Prev. 21, 504-12 (2012).
57. Walcott, F. et al. Telomere length and risk of glioma. Cancer Epidemiol. 37, 935-8 (2013).
58. Prescott, J., McGrath, M., Lee, I. M., Buring, J. E. & De Vivo, I. Telomere length and genetic analyses in population-based studies of endometrial cancer risk. Cancer. 116, 4275-82 (2010).
59. Weischer, M. et al. Short telomere length, cancer survival, and cancer risk in 47102 individuals. J Natl Cancer Inst. 105, 459-68 (2013).
60. Mirabello, L. et al. Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control. 21, 77-82 (2010).
61. Willeit, P. et al. Telomere length and risk of incident cancer and cancer mortality. JAMA. 304, 69-75 (2010).
62. Svenson, U. et al. Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res. 68, 3618-23 (2008).
63. Pooley, K. A. et al. Telomere length in prospective and retrospective cancer case-control studies. Cancer Res. 70, 3170-6 (2010).
64. Skinner, H. G. et al. Telomere length and pancreatic cancer: a case-control study. Cancer Epidemiol Biomarkers Prev. 21, 2095-100 (2012).
65. Campa, D. et al. Leukocyte telomere length in relation to pancreatic cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev. 23, 2447-54 (2014).
66. Wang, S. et al. Association between leukocyte telomere length and glioma risk: a case-control study. Neuro Oncol. 16, 505-12 (2014).
67. Lau, J., Ioannidis, J. P. & Schmid, C. H. Quantitative synthesis in systematic reviews. Ann Intern Med. 127, 820-6 (1997).
68. Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat Med. 21, 1539-58 (2002).
69. Petitti, D. Meta-analysis, decision analysis, and cost-effectiveness analysis. Oxford University Press (New York, 1994).
70. Blackburn, E. H. Switching and signaling at the telomere. Cell. 106, 661-73 (2001).
71. Hahn, W. C. Role of telomeres and telomerase in the pathogenesis of human cancer. J Clin Oncol. 21, 2034-43 (2003).
72. Campisi, J., Kim, S. H., Lim, C. S. & Rubio, M. Cellular senescence, cancer and aging: the telomere connection. Exp Gerontol. 36, 1619-37 (2001).
73. DePinho, R. A. The age of cancer. Nature. 408, 248-54 (2000).
74. Desmaze, C., Soria, J. C., Freulet-Marrière, M. A., Mathieu, N. & Sabatier, L. Telomere-driven genomic instability in cancer cells. Cancer Lett. 194, 173-82 (2003).
75. Broberg, K., Björk, J., Paulsson, K., Höglund, M. & Albin, M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis. 26, 1263-71 (2005).
76. O'Shaughnessy, J. A. et al. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res. 8, 314-46 (2002).
77. Meeker, A. K. et al. Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res. 62, 6405-9 (2002).
78. Basu, N. et al. Telomeres and telomere dynamics: relevance to cancers of the GI tract. Expert Rev Gastroenterol Hepatol. 7, 733-48 (2013).
79. Cesare, A. J. & Reddel, R. R. Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet. 11, 319-30 (2010).
80. Njajou, O. T. et al. Telomere length is paternally inherited and is associated with parental lifespan. Proc Natl Acad Sci USA 104, 12135-9 (2007).
81. Valdes, A. M. et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 366, 662-4 (2005).